PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

P7C3-A20 treatment one year after TBI in mice repairs the blood-brain barrier, arrests chronic neurodegeneration, and restores cognition.

Mouse / TBI

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 33087571 ↗2020Reported benefit

P7C3-A20 treatment one year after TBI in mice repairs the blood-brain barrier, arrests chronic neurodegeneration, and restores cognition.

MouseTBIBlast / overpressureC57BL/6JMalen = 15 sham-vehicle, 25 TBI-vehicle, 25 TBI-P7C3-A20; western b…Intraperitoneal10 mg/kg/day in vivo; 0.03-5 uM in vitroChronic arm began 12 months after a single TBI; acute arm dosed 18 h before and…

Model: Multimodal TBI using membrane rupture at 20 PSI generating an approximately 1.0-1.5 ms air jet of 137.9 +/- 2.09 kPa across the untethered head

P7C3-A20 started one year after TBI restored spatial memory, arrested axonal degeneration and repaired blood-brain barrier endothelium, tight junction proteins and pericyte density, although neuronal loss and motor slowing were not corrected.

Extraction: extract · Subtype source: llm · Supplied extraction confidence: 0.92. Machine-extracted fields require source verification.